Cascade Pharma Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
29
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
13
Cascade Pharma General Information
Description
Developer of therapeutics designed for metabolic and inflammatory diseases. The company utilizes structure-biology-driven drug design and first-principles thinking to target nuclear receptors and G protein-coupled receptors, providing healthcare professionals with non-steroidal farnesoid X receptor agonists, thyroid hormone receptor beta agonists, metabolic dysfunction-associated steatohepatitis therapeutics, primary biliary cholangitis treatments, obesity drugs, and diabetes medications to treat chronic liver diseases and inflammation.
Contact Information
Website
www.cascadepharm.comCorporate Office
- Building 6, Lane 908, Ziping Road
- Pudong New Area
- Shanghai, 201321
- China
Corporate Office
- Building 6, Lane 908, Ziping Road
- Pudong New Area
- Shanghai, 201321
- China
Cascade Pharma Timeline
Cascade Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cascade Pharma Comparisons
Industry
Financing
Details
Cascade Pharma Competitors (2)
One of Cascade Pharma’s 2 competitors is Pfizer (Vienna), a Corporation company based in Vienna, Austria.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| Pfizer Pakistan | Corporation | Karachi, Pakistan |
Cascade Pharma Patents
Cascade Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026184228-A1 | Combination of thr-β agonist and glp-1 receptor agonist | Pending | 07-Mar-2025 | ||
| WO-2026148995-A1 | Pharmaceutical composition comprising fxr agonist and glp-1 receptor small molecule agonist | Pending | 10-Jan-2025 | ||
| WO-2026055841-A1 | Aromatic ring-fused heterocyclic compound, preparation method therefor and use thereof | Pending | 11-Sep-2024 | ||
| EP-4821927-A1 | Benzo heterocyclic compound and use thereof | Pending | 06-Dec-2023 | ||
| WO-2025119263-A1 | Benzo heterocyclic compound and use thereof | Inactive | 06-Dec-2023 | C07D405/04 |
Cascade Pharma Signals
Cascade Pharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Cascade Pharma FAQs
-
When was Cascade Pharma founded?
Cascade Pharma was founded in 2017.
-
Where is Cascade Pharma headquartered?
Cascade Pharma is headquartered in Shanghai, China.
-
What is the size of Cascade Pharma?
Cascade Pharma has 29 total employees.
-
What industry is Cascade Pharma in?
Cascade Pharma’s primary industry is Drug Discovery.
-
Is Cascade Pharma a private or public company?
Cascade Pharma is a Private company.
-
What is Cascade Pharma’s current revenue?
The current revenue for Cascade Pharma is .
-
How much funding has Cascade Pharma raised over time?
Cascade Pharma has raised $265M.
-
Who are Cascade Pharma’s investors?
China Taiping Insurance (UK), Shanghai STVC Group, Yuekai Capital, China Life Investment Management Company, and Qingdao Guoxin are 5 of 28 investors who have invested in Cascade Pharma.
-
Who are Cascade Pharma’s competitors?
Pfizer (Vienna) and Pfizer Pakistan are competitors of Cascade Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process